Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hanson

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Biologie Aujourd'Hui|March 11, 2022
[G proteins: privileged transducers of 7-transmembrane spanning receptors]Julien Hanson
Journal of Medicinal Chemistry|November 17, 2023
Beware the Receptor VariantsJulien Hanson
Biochemical Pharmacology|July 4, 2016
GPCRs in immunity: Atypical receptors and novel conceptsJulien Hanson, Andy Chevigné
Drug Discovery Today|December 14, 2016
Chemokine neutralization as an innovative therapeutic strategy for atopic dermatitisDayana Abboud, Julien Hanson
Methods in Molecular Biology (Clifton, N.J.)|June 4, 2021
Nanoluciferase-Based Complementation Assay to Detect GPCR-G Protein InteractionCéline Laschet, Julien Hanson
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2021
Correction to: Nanoluciferase-Based Complementation Assay to Detect GPCR-G Protein InteractionCéline Laschet, Julien Hanson
The Journal of Biological Chemistry|December 30, 2018
A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactionsCéline Laschet, Nadine Dupuis, Julien Hanson
Biochemical Pharmacology|February 19, 2018
The G protein-coupled receptors deorphanization landscapeCéline Laschet, Nadine Dupuis, Julien Hanson
Frontiers in Endocrinology|December 5, 2022
Editorial: Emerging receptors as new targets in health and diseaseJulie Dam, Julien Hanson, Martyna Szpakowska
Pharmacology & Therapeutics|June 30, 2012
Role of HCA₂ (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skinJulien Hanson, Andreas Gille, Stefan Offermanns
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Biologie Aujourd'Hui|March 11, 2022
[G proteins: privileged transducers of 7-transmembrane spanning receptors]Julien Hanson
Journal of Medicinal Chemistry|November 17, 2023
Beware the Receptor VariantsJulien Hanson
Biochemical Pharmacology|July 4, 2016
GPCRs in immunity: Atypical receptors and novel conceptsJulien Hanson, Andy Chevigné
Drug Discovery Today|December 14, 2016
Chemokine neutralization as an innovative therapeutic strategy for atopic dermatitisDayana Abboud, Julien Hanson
Methods in Molecular Biology (Clifton, N.J.)|June 4, 2021
Nanoluciferase-Based Complementation Assay to Detect GPCR-G Protein InteractionCéline Laschet, Julien Hanson
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2021
Correction to: Nanoluciferase-Based Complementation Assay to Detect GPCR-G Protein InteractionCéline Laschet, Julien Hanson
The Journal of Biological Chemistry|December 30, 2018
A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactionsCéline Laschet, Nadine Dupuis, Julien Hanson
Biochemical Pharmacology|February 19, 2018
The G protein-coupled receptors deorphanization landscapeCéline Laschet, Nadine Dupuis, Julien Hanson
Frontiers in Endocrinology|December 5, 2022
Editorial: Emerging receptors as new targets in health and diseaseJulie Dam, Julien Hanson, Martyna Szpakowska
Pharmacology & Therapeutics|June 30, 2012
Role of HCA₂ (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skinJulien Hanson, Andreas Gille, Stefan Offermanns
Pageof 7